Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

3.460 -0.240 (-6.49%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

22 23 Next >

2 Beaten-Down Stocks With Incredible Upside Potential ↗

April 30, 2025

Via The Motley Fool

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

April 23, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Stock Is Crashing. And Here's Why Things Could Get Even Worse This Year. ↗

April 23, 2025

Via The Motley Fool

This Biotech Stock Could Be the Best Investment of the Decade ↗

April 19, 2025

There's an incredible growth story hiding in plain sight for investors who can look to the future.

Via The Motley Fool

Forecasting The Future: 4 Analyst Projections For Iovance Biotherapeutics ↗

February 28, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

What's Wrong With Iovance Biotherapeutics Stock? ↗

January 30, 2025

Via The Motley Fool

Where Will Iovance Biotherapeutics Be in 5 Years? ↗

January 29, 2025

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

April 18, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Is Iovance Biotherapeutics a Millionaire-Maker? ↗

April 14, 2025

Via The Motley Fool

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street ↗

April 07, 2025

Via The Motley Fool

Traws Pharma Announces Management Updates

March 28, 2025

From Traws Pharma, Inc.

Via GlobeNewswire

Top 3 Health Care Stocks That Are Set To Fly This Month ↗

March 26, 2025

Via Benzinga

1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street ↗

March 22, 2025

Via The Motley Fool

3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not ↗

March 22, 2025

The time to buy quality prospects is when the rest of the market is ignoring their value.

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

March 21, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Down Nearly 80% From Its High, Is Iovance Biotherapeutics Stock Too Cheap to Pass Up? ↗

March 12, 2025

Via The Motley Fool

These stocks are moving in today's after hours session ↗

February 27, 2025

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024

February 27, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 21, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

My 3 Favorite Stocks to Buy Right Now ↗

February 20, 2025

The market's underestimating how well each of these companies should be able to capitalize on their opportunities.

Via The Motley Fool

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025

February 18, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

February 12, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Shares Fell Today: What's Going On? ↗

February 10, 2025

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares closed lower on Monday potentially following the company's announcement of Dan Kirby as Chief Commercial Officer.

Via Benzinga

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

February 10, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Meet the Growth Stock That Could Soar 280%, According to Wall Street Analysts ↗

January 27, 2025

Via The Motley Fool

3 Stocks That Could Turn $1,000 Into $5,000 by 2030 ↗

January 18, 2025

A handful of bullish factors are converging at the right time in the right way for all three of these companies.

Via The Motley Fool

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

January 17, 2025

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Shares Are Falling Today: What's Going On? ↗

January 10, 2025

Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) are trading lower Friday. The company announced the inducement stock option grants under Nasdaq Listing Rule 5635(c)(4).

Via Benzinga

3 Mid-Cap Stocks That Could Take Off in 2025 ↗

January 09, 2025

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.